Cargando…
Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations
Influenza viruses of types A and B attack 5–10% of adults and 20–30% of children, thereby causing millions of acute respiratory infections in Germany annually. A significant number of these infections are associated with complications such as pneumonia and bacterial superinfections that need hospita...
Autores principales: | Duwe, Susanne C., Schmidt, Barbara, Gärtner, Barbara C., Timm, Jörg, Adams, Ortwin, Fickenscher, Helmut, Schmidtke, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165743/ https://www.ncbi.nlm.nih.gov/pubmed/34113534 http://dx.doi.org/10.3205/id000071 |
Ejemplares similares
-
Influenza viruses – antiviral therapy and resistance
por: Duwe, Susanne
Publicado: (2017) -
IL-26: An Emerging Proinflammatory Member of the IL-10 Cytokine Family with Multifaceted Actions in Antiviral, Antimicrobial, and Autoimmune Responses
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2016) -
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients
por: Ghanbari, Reza, et al.
Publicado: (2021) -
Antiviral Immunity and Prophylaxis
Publicado: (2011) -
Preparing for the Next Influenza Season: Monitoring the Emergence and Spread of Antiviral Resistance
por: Oh, Djin-Ye, et al.
Publicado: (2023)